Contrasting Hypertension Diagnostics (OTCMKTS:HDII) and UFP Technologies (NASDAQ:UFPT)

Hypertension Diagnostics (OTCMKTS:HDIIGet Free Report) and UFP Technologies (NASDAQ:UFPTGet Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

Risk and Volatility

Hypertension Diagnostics has a beta of -2.32, meaning that its stock price is 332% less volatile than the S&P 500. Comparatively, UFP Technologies has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.


This table compares Hypertension Diagnostics and UFP Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hypertension Diagnostics N/A N/A N/A
UFP Technologies 10.72% 25.37% 16.47%

Earnings and Valuation

This table compares Hypertension Diagnostics and UFP Technologies’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Hypertension Diagnostics N/A N/A N/A N/A N/A
UFP Technologies $353.79 million 3.77 $41.79 million $5.44 32.12

UFP Technologies has higher revenue and earnings than Hypertension Diagnostics.

Insider & Institutional Ownership

84.6% of UFP Technologies shares are held by institutional investors. 40.0% of Hypertension Diagnostics shares are held by company insiders. Comparatively, 7.8% of UFP Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings for Hypertension Diagnostics and UFP Technologies, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hypertension Diagnostics 0 0 0 0 N/A
UFP Technologies 0 1 1 0 2.50

UFP Technologies has a consensus price target of $222.00, suggesting a potential upside of 27.06%. Given UFP Technologies’ higher probable upside, analysts plainly believe UFP Technologies is more favorable than Hypertension Diagnostics.


UFP Technologies beats Hypertension Diagnostics on 8 of the 9 factors compared between the two stocks.

About Hypertension Diagnostics

(Get Free Report)

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.

About UFP Technologies

(Get Free Report)

UFP Technologies, Inc. designs, engineers, and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for orthopedic implants, orthopedic appliances, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; recycled protective packaging for business-to-consumer brands primarily focused on electronics, candles, wine, and other high-volume consumer products; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Receive News & Ratings for Hypertension Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypertension Diagnostics and related companies with's FREE daily email newsletter.